Nature Communications (Mar 2021)

Hyocholic acid species as novel biomarkers for metabolic disorders

  • Xiaojiao Zheng,
  • Tianlu Chen,
  • Aihua Zhao,
  • Zhangchi Ning,
  • Junliang Kuang,
  • Shouli Wang,
  • Yijun You,
  • Yuqian Bao,
  • Xiaojing Ma,
  • Haoyong Yu,
  • Jian Zhou,
  • Miao Jiang,
  • Mengci Li,
  • Jieyi Wang,
  • Xiaohui Ma,
  • Shuiping Zhou,
  • Yitao Li,
  • Kun Ge,
  • Cynthia Rajani,
  • Guoxiang Xie,
  • Cheng Hu,
  • Yike Guo,
  • Aiping Lu,
  • Weiping Jia,
  • Wei Jia

DOI
https://doi.org/10.1038/s41467-021-21744-w
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

The early identification of metabolic disorders could improve or prevent overt disease. Here the authors show that the circulating concentration of hyocholic acid (HCA) species is decreased in the context of obesity and diabetes and increased after gastric bypass surgery in humans, and further that serum HCA species are predictive of metabolic outcomes in healthy individuals.